Physician

Al Benson, MD

According to 2025 Medicare claims, Al Benson, MD (NPI: 1891761532) practices medical oncology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is NORTHWESTERN MEDICAL FACULTY FOUNDATION (NPI: 1346235314; TIN: 363097297) and primary practice location at 60611-2027. Benson is affiliated with the Northwestern Medicine Physician Network ACO (ACO ID: A2620), participating under the MSSP model.

Benson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 273 traditional Medicare patients, billed 61,277 HCPCS/CPT codes, and received $1,440,104 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 62 prescription claims across 18 beneficiaries totaling $204,878 in drug costs, led by Lonsurf (Trifluridine/Tipiracil Hcl). 2020 DME data shows 23 claims. Open Payments data shows 31 records totaling $145,868. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $695,363 to $1,440,104. In contrast, Part D prescription costs have declined steadily, from $409,685 to $204,878. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	320	36,083	$695,363
2016	363	50,601	$1,053,522
2017	310	39,709	$863,293
2018	334	41,664	$1,033,941
2019	383	73,651	$1,515,878
2020	342	65,295	$1,472,004
2021	295	49,904	$1,122,959
2022	324	52,891	$1,177,985
2023	300	55,640	$1,519,758
2024	273	61,277	$1,440,104

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	39	165	$409,685
2016	28	160	$400,252
2017	48	198	$192,237
2018	39	165	$198,001
2019	42	98	$116,922
2020	27	75	$196,852
2021	22	55	$57,179
2022	22	44	$116,042
2023	37	111	$110,540
2024	18	62	$204,878

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	43	299	$53,685
2016	N/R	82	$6,947
2017	N/R	37	$8,452
2018	N/R	11	$207
2019	N/R	89	$9,033
2020	N/R	23	$1,699
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	87	119	$104
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	47	61	$99
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	47	79	$51
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	66	92	$13
96375	Injection of additional new drug or substance into vein	54	99	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lonsurf	Trifluridine/Tipiracil Hcl	24	672	$102,845
Creon	Lipase/Protease/Amylase	14	655	$68,741

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	26	$31,360	Takeda Pharmaceuticals U.S.A., Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	5	$114,508	Celgene Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Al Benson, MD?

Tedicare shows public-source Medicare data for Al Benson, MD (NPI 1891761532), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Al Benson, MD have ACO affiliation data?

Al Benson, MD is shown with ACO affiliation data for Northwestern Medicine Physician Network ACO (MSSP, ACO ID A2620).

What billing organization is linked to Al Benson, MD?

Al Benson, MD is linked to NORTHWESTERN MEDICAL FACULTY FOUNDATION (billing NPI 1346235314) in the available physician profile data.

Does Al Benson, MD have Open Payments data?

Al Benson, MD has 31 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.